Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $48
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James maintains an Overweight rating on Progyny (NASDAQ:PGNY) and raises the price target from $45 to $48.
September 14, 2023 | 1:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has maintained an Overweight rating on Progyny and raised the price target from $45 to $48.
The news of Cantor Fitzgerald maintaining an Overweight rating and raising the price target for Progyny is likely to be seen as a positive signal by the market, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100